PET/CT Imaging of 64CU-Labelled HER2 Liposomal Doxorubicin (64CU-MM-302) Quantifies Variability of Liposomal Drug Delivery to Diverse Tumor Lesions in HER2-Positive Breast Cancer Patients

Bart S. Hendriks, Anthony F. Shields, Barry A. Siegel, Kathy D. Miller, Pamela N. Münster, Karen Campbell, V. Moyo, Thomas J. Wickham, P. LoRusso

Annals of Oncology · 2014 · 10 citations · 0 references

DOIFull text

Open access

Concepts